Skip to content

A study to assess the effectiveness of Arundo Mauritanica in the homoeopathic management of Allergic Rhinitis among adults

Effectiveness of Aruno Mauritanica in Homoeopathic Management Of Allergic Rhinitis among adults:An non-controlled experimental study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112266
Enrollment
38
Registered
2026-06-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Arundo Mauritanica: Homoeopathic remedy Arundo Mauritanica will be administered orally in globule form as per Homoeopathic principles in appropriate potency i.e potencies above 3c accor

Sponsors

Dr. G.D.Pol Foundation, Y.M.T. Homoeopathic Medical College, Hospital and P.G. Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed patients among Adult age 21 to 40 years. Patients of all genders Patient diagnosed with Perennial Allergic Rhinitis Patient from all socio economics backgrounds Subjects willing to give informed written consent.

Exclusion criteria

Exclusion criteria: Pregnant and Lactating Females. Patient with suspected immune-compromised state Patient with associated with allergic Respiratory disorder Asthma, sinusitis Patients on any medication within 1 months prior to study. Patient having any systemic diseases DM, HTN, CKD.

Design outcomes

Primary

MeasureTime frame
Total Nasal Symptom ScoreTimepoint: Baseline, 1 month, 3 month, 6 Months

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Chintan Mehta

Dr. G.D. Pol Foundation, Y.M.T. Homoeopathic Medical College, Hospital and P.G. Institute

neelamaswale@yahoo.com9930782083

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026